Image provided by: University of Oregon Libraries; Eugene, OR
About Just out. (Portland, OR) 1983-2013 | View Entire Issue (Oct. 3, 2003)
ïliM U news Those changes have "caused omestic AIDS programs concerns among state HIV/AIDS got none of the necessary directors," wrote Democratic Leader increases in funding when Nancy Pelosi of California, Deputy the U.S. Senate voted on Meanwhile, House Democrats protest tightened CDC review of prevention materials Leader Steny Hover of Maryland the appropriations hill and Henrv Waxman of California, Sept. 10. It. marked the end ot hroad by Bob R oehr __________ ____________ _ the ranking member of the commit bipartisan support tor AIDS programs in tee, to Health Secretary Tommy general and the AIDS Drug Assistance Thomp>son in their Sept. 11 letter. Program in particular that had survived tor more Terje Anderson, Under guidelines established in 1992, than a decade. National Associa after long discussion, local Program Sen. Charles Schumer. D-N.Y., ottered an tion ot People with Review Panels screen materials for their amendment to the House/Labor Health and AIDS executive appropriateness for rhe targeted audience. Human Services appropriations hill that would director, said the The panels also must make sure they com have added $2148 million to ADAP. It was Senate has heard ply with a federal law requiring that they mled out ot order hy the chair because it would this from its con- are not “designed to promote or encourage, exceed discretionary spending caps already set bv stituents “but refus directly, homosexual or heterosexual activ to increase the Senate. A motion to overrule the chair was es ity or intravenous substance abuse"; point ADAP and Ryan defeated by a largely party-line vote ot 44-5 3. out the harmful effects of such activities; Sen. Richard Durbin. D-lll., ottered an White CARE Act and address rhe benefits of abstaining from amendment to increase funding tor internation funding bv even the all of them. al AIDS efforts, and that was defeated in a sim $100 million that rhe president pro The authors charged that rhe CDC has ilar manner. "The crisis started building two vears ago and posed.” He was added another layer of bureaucracy by requiring “a certification that accountable now i> in lull bloom," said Jules Levin, executive “extremely disap director ot the National AIDS Treatment pointed." state or U>cal health officials indejvndently review" the materials. The terminology of David Munar, AIDS funding amendments proposed bv Democratic Sens. Charles Schumer of Advocacy Project. “ADAP has been underfund ed, and states have been unable to continue pro AIDS Foundation New York (left) and Richard Durbin of Illinois were defeated in partv-line votes the requirement is not defined, and the viding access to HIV treatment at the same lev of Chicago associ CDC is offering no additional hinds for the els as before.” ate director, lamented, “The Senate is honestly Senate meet in conference to resolve differ added burden at a time when most states face a Many states have made it harder to qualify considering giving the Bush administration an ences between the two versions ot the appro severe budget crunch. They asked Thompson to reconsider the t< >r the program; cut back on the number ot additional $87 billion tor a questionable war and priations bill. On the other side ot the Capitol, three rank changes and “to make any future changes only drugs that are covered or delayed adding newly foreign occupation but can’t seem to find a wav approved drugs; or established waiting lists. to make $400 million available to care tor its ing Democrats in the U.S. House ot Representa after thorough analysis and full consultation tives have written the Bush administration with the stakeholder groups and Congress." JH Three HIV-positive people recently died while own citizens in need.” i 'ii an ADAP waiting list in West Virginia, and AIDS advocates hold out a small glimmer ot protesting changes in the way that HIV preven i estimated 1,200 people will be on those lists hope that they will be able to get at least some tion materials are reviewed bv the Centers tor Dis- ROB R oehr is a free-lance reporter based in Washington, D . C . Kv the end of the year. ot the necessary money when the House anil ease Control and Prevention prior to their use. AIDS F unding S tagnates T & by the U.S. military so that each retains its indi ational Institute of Allergy and vidual identity and strengths but is conducting Infectious Diseases director research to common standards and operating Anthony Fauci called for “a procedures. moral commitment...to a vision Perhaps the most expensive element of and a strategic plan to help Conference envisions HIV vaccine research by Bob R oehr research is the ability to conduct Phase III clin iccelerate the development of an HIV vaccine" n his plenary address to the AIDS Vaccine and identifying and meeting human and physi Many people both within and outside the ical trials that prove a vaccine works. The research community believe HIV vaccine National Institutes of Health are working with ,003 conference held in New York City from cal infrastructure needs. ^ p t. 18 to 21. Participation in the Enterprise “is not by sub research has been fragmented and disjointed. • academic and organizational partners in devel The concepts of what has become known as scription, it is by community," said Jose Esparza, Work in the lab and in monkey studies bas been oping countries to create that capacity. "Industry is an absolutely essential partner" rhe “Global Enterprise" were first launched in director of HIV vaccine activities with the done to differing standards and has used differ ent assays or measuring tools, making it often for Fauci, and “taking away some of the risk" tor in article last June in the magazine Science by World Health Organization. wo dozen authors, including Fauci. Further dis- “The real challenge is to change our behav impossible to compare the results and reach industry in this area is part of NlH’s mandate. ussion ensued at an August meeting in Airlie, ior,” added Larry Corey, a University of Wash broader conclusions. “We have these clinical But he also made clear, “If they want to utilize /a., and during the next six months working ington researcher who is principal investigator networks—lets make sure these trials are com the many facilities that we have, we would like roups will develop a strategic plan for the for the international HIV Vaccine Trials Net patible with each other so that we don’t waste them to do it in a way that the knowledge that is gained is going to be helpful to the field." Enterprise. work, which is supported financially by the time and resources," Fauci said. “A trial could fail to get you a vaccine," he The National Institute of Allergy and Infec Fauci said key principles are a commitment National Institutes of Health. to working together as a global community; “to Fauci called developing an HIV vaccine “clear tious Diseases received a mandate from Health explained, "but it could allow you to leam a lot ensure transparency and systematic communica ly the most important and indeed the most diffi Secretary Tommy Thompson to coordinate all about what you arc going to do" in future itera tions platfonus”; common laboratory standards cult and problematic challenge in AIDS research." HIV vaccine research funded by the U.S. gov tions. “That is why transparency and harmo to allow comparability between efforts and their In searching for correlates of protection, “We are ernment. It now is coordinating efforts by the nization and common laboratory parameters are Centers for Disease Control and Prevention and so important." JH integration into the larger scheme of research; looking for something that isn’t there." N G lobal E nterprise N ext A ùventure P ortlands A lt € rmati 'J€ S porting G o o d i 9 tor € ® 1 ? i>[i in ap te & (Hommes] \
